Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024)
Verastem (VSTM) recorded quarterly Change in Acquisitions & Divestments of $29.0 million in Q2 2024, down 6.45% quarter-over-quarter from $31.0 million in Q1 2024, and up 107.14% on a YoY basis from $14.0 million in Q3 2023.
Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024) Analysis & Trends
Verastem's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $29.0 million for Q2 2024.
- In Q2 2024, Change in Acquisitions & Divestments rose 107.14% year-over-year to $29.0 million; the TTM figure through Dec 2024 stood at $60.0 million (up 15.38% YoY), while the FY2024 annual figure was $60.0 million, up 15.38% from the prior year.
- Change in Acquisitions & Divestments was $29.0 million for Q2 2024 at Verastem, down from $31.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $38.1 million in Q2 2021 to a low of $5.4 million in Q1 2021.
- Historically, Change in Acquisitions & Divestments has averaged $22.5 million across 5 years, with a median of $24.6 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments slumped 83.23% in 2021, then jumped 351.16% in 2022.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $32.0 million in 2020, then advanced by 3.74% to $33.2 million in 2021, then plunged by 53.38% to $15.5 million in 2022, then jumped by 61.29% to $25.0 million in 2023, then advanced by 16.0% to $29.0 million in 2024.
- The last three Change in Acquisitions & Divestments figures came in at $29.0 million (Q2 2024), $31.0 million (Q1 2024), and $25.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 29.00 Mn |
| Jun 30, 2024 | 29.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Dec 31, 2021 | 33.25 Mn |
| Dec 31, 2021 | 33.25 Mn |